MedPath

The head-to-head comparison between escitalopram and mirtazapine for anxiety and agitation on the patients with depression, especially for the efficacy and safety.

Not Applicable
Suspended
Conditions
depression
Registration Number
JPRN-UMIN000014609
Lead Sponsor
europsychiatry dept., Osaka Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

The patients who does not have the insight

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical symptom scaled by HAM-A, HAM-D, and MADRS
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath